ArticleArthritis research & therapy2026

Clinical and MRI remission in axial spondyloarthritis: one-year outcomes and predictors from the TRACE treat-to-target study with secukinumab.

Nora Vladimirova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.